administered orally any one of a number of injection methods including intramuscular intravenous subcutaneous and intradermal are preferred in addition administration routes such as the subcutaneous implantation of naloxone containing microcapsules or a transdermal patch system are also contemplated all of these indicated delivery routes lend themselves to the local administration of naloxone at or near the nerve trauma site since local rather than systemic administration of naloxone has proven more effective in the treatment of pain the former administration route is preferred in the treatment method of the present invention as used herein the term 34 pain syndrome 34 or 34 nerve injury induced pain 34 refers to debilitating pain and its attendant symptoms such as a limited range of bodily motion decreased muscular strength numbness parethesia and dysesthesia and the like caused by nerve injury this is meant to include both peripheral nerve injury as well as central nerve injury such as is associated with spinal cord injury by one preferred method that involving some form of local injection the effective dose of naloxone is administered to a patient once daily for anywhere from three to six months again however it may be necessary for a given patient to receive a second daily effective dose of naloxone and or extend the total treatment period beyond the 34 typical 34 six months in addition to the foregoing treatment schedule the preferred method of the present invention also contemplates the adjunctive use of other pharmacological and or non pharmacological treatments for patients with nerve injury induced pain syndrome of course such adjunctive treatments will vary depending upon a particular patient 39 s diagnosis however the typical course of treatment preferably includes some adjunctive treatment for the duration of the six month period wherein the.